How can advances in cannabinoid delivery systems improve therapeutic outcomes for patients?
How can advances in cannabinoid delivery systems improve therapeutic outcomes for patients? Advances in cannabinoid delivery systems can enhance therapeutic outcomes by optimizing absorption, improving bioavailability, and enabling controlled release of cannabinoids. Innovative delivery methods, such as transdermal patches, inhalation devices, and nanoparticle formulations, can provide targeted and sustained effects while minimizing side effects. These systems can also facilitate precise dosing, allowing for personalized treatment plans tailored to individual patient needs. Additionally, enhancing cannabinoid formulations to improve stability and solubility can lead to more effective and reliable therapeutic options. By leveraging advancements in delivery technologies, researchers and clinicians can improve the overall efficacy and safety of cannabinoid therapies (Wilkinson et al., 2020).